Manitou Investment Management Ltd. Has $1.91 Million Stake in Danaher Corporation $DHR

Manitou Investment Management Ltd. raised its position in Danaher Corporation (NYSE:DHR) by 76.2% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 10,049 shares of the conglomerate’s stock after buying an additional 4,345 shares during the quarter. Danaher comprises about 0.4% of Manitou Investment Management Ltd.’s portfolio, making the stock its 17th largest holding. Manitou Investment Management Ltd.’s holdings in Danaher were worth $1,914,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Elevated Capital Advisors LLC bought a new position in Danaher in the fourth quarter valued at approximately $26,000. Hilton Head Capital Partners LLC bought a new stake in Danaher during the fourth quarter worth $27,000. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Danaher in the 3rd quarter valued at $25,000. Finally, Main Street Group LTD bought a new position in shares of Danaher in the 1st quarter valued at $25,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $200.01 on Friday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The business has a 50-day simple moving average of $190.23 and a two-hundred day simple moving average of $194.24. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock has a market cap of $140.61 billion, a PE ratio of 35.53, a PEG ratio of 2.49 and a beta of 0.78.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period last year, the firm posted $0.77 earnings per share. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. Analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. lowered their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Jefferies Financial Group reissued a “buy” rating and issued a $245.00 target price on shares of Danaher in a report on Tuesday, April 21st. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Finally, The Goldman Sachs Group lowered their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.